We are live on ! Find out more
PFE icon

Pfizer
PFE

2,931 hedge funds and large institutions have $97.4B invested in Pfizer in 2025 Q1 according to their latest regulatory filings, with 178 funds opening new positions, 1,283 increasing their positions, 1,201 reducing their positions, and 190 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more funds holding in top 10

Funds holding in top 10: 42 → 44 (+2)

7% more repeat investments, than reductions

Existing positions increased: 1,283 | Existing positions reduced: 1,201

0.01% more ownership

Funds ownership: 66.25% → 66.26% (+0.01%)

3% less capital invested

Capital invested by funds: $100B → $97.4B (-$2.71B)

6% less first-time investments, than exits

New positions opened: 178 | Existing positions closed: 190

2% less funds holding

Funds holding: 2,996 → 2,931 (-65)

23% less call options, than puts

Call options by funds: $2.98B | Put options by funds: $3.87B

Holders
2,931
Holders Change
-65
Holders Change %
-2.17%
% of All Funds
39.29%
Holding in Top 10
44
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+4.76%
% of All Funds
0.59%
New
178
Increased
1,283
Reduced
1,201
Closed
190
Calls
$2.98B
Puts
$3.87B
Net Calls
-$897M
Net Calls Change
-$302M

Top Buyers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
+$950M
2
BlackRock
BlackRock
New York
+$587M
3
Pacer Advisors
Pacer Advisors
Pennsylvania
+$470M
4
Amundi
Amundi
France
+$412M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$342M

Top Sellers

Rank Fund Capital Flow
1
Charles Schwab
Charles Schwab
California
-$2.81B
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$955M
3
Capital World Investors
Capital World Investors
California
-$429M
4
1832 Asset Management
1832 Asset Management
Ontario, Canada
-$261M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$239M
Name Holding Trade Value Shares
Change 		Change in
Stake
UA
976
Unison Advisors
District of Columbia
$2.29M +$37.2K +1,420 +2%
AFM
977
Anson Funds Management
Texas
$2.28M -$785K -30,000 -25%
SFM
978
Sphera Funds Management
Israel
$2.28M – – –
RPI
979
Railway Pension Investments
United Kingdom
$2.28M +$2.35M +89,900 New
PCM
980
Prelude Capital Management
New York
$2.28M +$537K +20,503 +30%
MIA
981
MMBG Investment Advisors
Florida
$2.28M -$41.7K -1,593 -2%
CB
982
Community Bank
New York
$2.27M +$309K +11,796 +15%
KFGK
983
Keystone Financial Group (Kentucky)
Kentucky
$2.27M +$524K +20,039 +29%
FF
984
Fluent Financial
Texas
$2.27M +$2.34M +89,513 New
CNFG
985
Creegan & Nassoura Financial Group
New Hampshire
$2.27M – – –
KFS
986
Keynote Financial Services
Connecticut
$2.26M +$114K +4,353 +5%
OPA
987
Old Port Advisors
Maine
$2.26M +$189K +7,218 +9%
LWCFA
988
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2.26M -$29.2K -1,116 -1%
S
989
SignatureFD
Georgia
$2.26M +$247K +9,454 +12%
CWM
990
Cornerstone Wealth Management
Missouri
$2.25M +$172K +6,592 +8%
PS
991
Principal Securities
Iowa
$2.25M +$7.64K +292 +0.3%
LA
992
Lynch & Associates
Indiana
$2.25M -$21K -802 -0.9%
VNIM
993
Vaughan Nelson Investment Management
Texas
$2.25M – – –
IP
994
Intellectus Partners
California
$2.25M -$288K -11,016 -11%
CIA
995
Cohen Investment Advisors
New Hampshire
$2.24M +$264K +10,097 +13%
ONSWM
996
Old North State Wealth Management
North Carolina
$2.24M +$231K +8,812 +11%
PAM
997
Panagora Asset Management
Massachusetts
$2.23M +$81.9K +3,128 +4%
HCA
998
Harbor Capital Advisors
Illinois
$2.23M -$698K -26,685 -23%
BMO
999
Beck Mack & Oliver
New York
$2.22M +$39.3K +1,500 +2%
GWM
1000
Glass Wealth Management
Texas
$2.21M -$448K -17,129 -16%
38 39
40
41 42

PFE Hedge Fund Activity: Q1 2025 in Review

2,931 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2025, worth a combined $97.4B — down 2.7% from $100B a quarter earlier.

Sellers outnumbered buyers: 190 funds closed out of PFE and 178 opened new positions — a net loss of 12 holders — while 1,201 trimmed existing stakes and 1,283 added.

The largest buyer was Fisher Asset Management, adding an estimated $950M. The largest seller was Charles Schwab, cutting an estimated $2.81B.

  • 2,931 institutional investors held Pfizer (PFE) as of Q1 2025, down from 2,996 in Q4 2024.
  • Funds reported $97.4B of Pfizer stock for Q1 2025, down 2.7% quarter-over-quarter.
  • 178 funds opened new Pfizer positions in Q1 2025 and 190 closed out, a net change of -12 holders.
  • The largest Pfizer buyer in Q1 2025 was Fisher Asset Management, an estimated $950M added.
  • The largest Pfizer seller in Q1 2025 was Charles Schwab, an estimated $2.81B sold.

Based on aggregated 13F filings for Q1 2025.